Comparatively, the combination of resveratrol and piceatannol acts synergistically, leading to a more pronounced induction of PD-L1 expression in selected cancer cells derived from different anatomical sites including breast, colon and prostate cancer cells, and melanoma. Here, CD274 is linked to melanoma.